Larry Abensur

Larry Abensur is the founder of All.
Diag SAS (1993), Biosynex SA (2005) as Chairman & Chief Executive Officer, and Dectra Pharm SAS (1994) as Chairman.
Current jobs include Chairman at Gie Lab Otc, Chairman at Biosynex Swiss SA, Chairman at Biosynex Premier SA, President & Director at Chembio Diagnostics, Inc. (2023), Director at Theradiag SA (2022), Director at ProciseDx LLC, Co-Managing Director at Chembio Diagnostics Holdings Germany GmbH, Director at BHR Pharmaceuticals Ltd., Director at Biosynex Nordic A, Manager at ALA Financière SARL, Manager at ALM SARL, Manager at SCI La Chapelle D'Armentieres, Manager at Adele SARL, Manager at Ala SCI, Manager at Alb SCI, Manager at Alc SCI, Manager at Ald SCI, Manager at Ale SCI, Manager at Alt SCI, Manager at Alf SCI, Manager at Als SCI, Manager at ALG SCI, Manager at ALN SCI, Manager at ALO SCI, Manager at ABP SCI, Manager at La Pastille SCI, Manager at ALV SCI, Manager at ABC SCI, Manager at Rafale SCI, Manager at Abexo SCI, Manager at Betty SCI, and President at Biosynex US Holding, Inc. Former jobs include Chairman at Prodiag SAS, Chairman at Magnien SAS, Chairman at Laboratoire SBH SAS, Chairman at Qualigen, Inc., Managing Director at PBS Orgenics, Product Manager-Human Biosynthetic Insulin at Eli Lilly & Co., and Marketing Manager-France Region at The Upjohn Co. Education includes an MBA from INSEAD and an undergraduate degree from École Nationale Supérieure de Chimie de Paris.